Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and ...
NanoXplore Inc. (TSXV: NNX), a leader in graphene production with a market capitalization of $291.2 million, reported its financial results for the second quarter of 2024, highlighting a significant ...
13h
Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 PatientsSHIELD II Enrolled more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback